Renal-assessment update issued for dabigatran - TheHeart.Org PDF Print
TheHeart.Org
Ingelheim am Rhein, Germany - Boehringer Ingelheim is cautioning doctors in Europe to evaluate their patients' renal function prior to treatment with dabigatran etexilate (Pradaxa) and to continue renal assessment whenever a possible decline in renal ...
Boehringer Ingelheim Implements Additional Guidance Supporting Appropriate Use

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.